Grabar Law Office Investigates Potential Claims Against Officers and Directors of Odonate Therapeutics, Inc. After an Agreement to Settle Class Action for $12.5 Million
Grabar Law Office Investigates Potential Claims Against Officers and Directors of Odonate Therapeutics, Inc. After an Agreement to Settle Class Action for $12.5 Million
Philadelphia, Pennsylvania--(Newsfile Corp. - May 26, 2022) - Odonate Therapeutics Inc. (NASDAQ: ODT) (OTC: ODTC) has agreed to pay $12.5 million to resolve a proposed securities class action in alleging the pharmaceutical company misled investors about the safety of a new drug for treating cancer. The lawsuit accused the company of making misleading statements and omissions about the development of tesetaxel. The amended complaint alleged that the company and its officers unlawfully inflated the stock price by misleading investors about a clinical trial and the likelihood of FDA approval.
賓夕法尼亞州費城---（新聞檔-2022 年 5 月 26 日）-Odonate 治療股份有限公司（NASDAQ：ODT）（場外交易代碼：OTC）已同意支付 1,250 萬美元，以解決擬議的證券集體訴訟，指控製藥公司誤導投資者有關治療癌症的新藥的安全性。訴訟指控該公司對 TEsetaxel 的發展作出誤導性陳述和遺漏。經修訂的投訴指，該公司及其職員誤導投資者對一項臨床試驗及獲得食品和藥物管理局批准的可能性，使股價非法誇大。
Current Odonate shareholders who have held shares of Odonate stock since at least December 7, 2017, can seek corporate reforms, the return of funds back to company coffers, and potentially a court approved incentive award if appropriate.
自 2017 年 12 月以來已經持有 Odonate 股票股份的當前 Odonate 股東 7, 2017, 可以尋求企業改革, 資金返還給公司保險箱, 並有可能在適當的情況下法院批准的獎勵獎勵.
If you would like to learn more about this matter at no cost to you, please contact us at jgrabar@grabarlaw.com or call 267-507-6085.
如果您想了解有關此事的更多信息，請通過以下方式與我們聯繫：jgrabar@grabarlaw.com 或致電 267-507-6085 與我們聯繫。
Attorney Advertising Disclaimer
律師廣告聲明
These materials have been prepared by the Grabar Law Office for informational purposes only and does not constitute legal advice. This information is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Prior results referred to in these materials do not guarantee or suggest a similar result in other matters.
這些材料由格拉巴律師事務所準備，僅供參考，並不構成法律意見。這些信息不是為了創建, 和接收它不構成, 律師與客戶的關係.這些材料中提到的先前結果並不保證或暗示其他事項的類似結果。
Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: jgrabar@grabarlaw.com
聯繫方式：
約書亞 ·H· 格拉巴, 等.
格拉巴律師事務所
自由广场一号
市場街 1650 號套房
费城
電話：二六七五七六零八五
電郵地址:jgrabar@grabarlaw.com
To view the source version of this press release, please visit
如欲查看此新聞稿的來源版本，請瀏覽
譯文內容由第三人軟體翻譯。